Solaris Endovascular, Inc. announced that the DEScover clinical trial has completed enrollment. According to the comp ...

The share price of Solaris Energy Infrastructure, Inc. (NYSE:SEI) surged by 14.64% between December 30, 2025, and January 6, ...

Enrollment milestone achieved ahead of schedule as Solaris DE drug-eluting continues to gather additional clinical ...

The S&P 500 energy sector (XLE) advanced 3.2% in the past year, widely lagging the broader markets, which rose 16.7%. In December, XLE moved 2.1% in the downward direction, while Crude oil futures ...

Assumes the exchange of all outstanding Solaris LLC Units for shares of Class A common stock at the beginning of the relevant reporting period, resulting in the elimination of the non-controlling ...

View source version on businesswire.com: https://www.businesswire.com/news/home/20251103631789/en/ The articles, information, and content displayed on this webpage ...